These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

46 related items for PubMed ID: 8216302

  • 21. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ, Champion HC, Rajasekaran M, Sikka SC, Kadowitz PJ, Doherty PC, Hellstrom WJ.
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [Abstract] [Full Text] [Related]

  • 22. Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: role of Gi and calcium.
    Lin WW, Chuang DM.
    Mol Pharmacol; 1993 Jul; 44(1):158-65. PubMed ID: 8341270
    [Abstract] [Full Text] [Related]

  • 23. Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin.
    Johansson SM, Lindgren E, Yang JN, Herling AW, Fredholm BB.
    Eur J Pharmacol; 2008 Nov 12; 597(1-3):92-101. PubMed ID: 18789919
    [Abstract] [Full Text] [Related]

  • 24. Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes.
    A-Rahim YI, Beyer KH, Vesell ES.
    Pharmacology; 1996 Oct 12; 53(4):197-210. PubMed ID: 8958558
    [Abstract] [Full Text] [Related]

  • 25. Specific inhibition of the cGMP-inhibited cAMP phosphodiesterase blocks the insulin-like antilipolytic effect of growth hormone in rat adipocytes.
    Eriksson H, Tornqvist H.
    Mol Cell Biochem; 1997 Apr 12; 169(1-2):37-42. PubMed ID: 9089629
    [Abstract] [Full Text] [Related]

  • 26. Adenylyl cyclase inhibitory pathway is differentially modified in rat white and brown fat by high-energy diets.
    Kenan Y, Levinson M, Pines M, Naim M.
    Am J Physiol; 1997 Jun 12; 272(6 Pt 1):E1043-9. PubMed ID: 9227450
    [Abstract] [Full Text] [Related]

  • 27. Antilipolytic effect of calcium-sensing receptor in human adipocytes.
    Cifuentes M, Rojas CV.
    Mol Cell Biochem; 2008 Dec 12; 319(1-2):17-21. PubMed ID: 18622738
    [Abstract] [Full Text] [Related]

  • 28. Action of insulin modulated by pertussis toxin in rat adipocytes.
    Goren HJ, Northup JK, Hollenberg MD.
    Can J Physiol Pharmacol; 1985 Aug 12; 63(8):1017-22. PubMed ID: 3907810
    [Abstract] [Full Text] [Related]

  • 29. Ablation of a galectin preferentially expressed in adipocytes increases lipolysis, reduces adiposity, and improves insulin sensitivity in mice.
    Yang RY, Yu L, Graham JL, Hsu DK, Lloyd KC, Havel PJ, Liu FT.
    Proc Natl Acad Sci U S A; 2011 Nov 15; 108(46):18696-701. PubMed ID: 21969596
    [Abstract] [Full Text] [Related]

  • 30. W-5 and quin 2-AM reverse the inhibitory effect of insulin on lipolysis due to dibutyryl cAMP.
    Goko H, Matsuoka A.
    Diabetes Res Clin Pract; 1999 May 15; 44(2):101-6. PubMed ID: 10414928
    [Abstract] [Full Text] [Related]

  • 31. Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations.
    Gasic S, Tian B, Green A.
    J Biol Chem; 1999 Mar 05; 274(10):6770-5. PubMed ID: 10037777
    [Abstract] [Full Text] [Related]

  • 32. G-proteins and insulin signaling.
    Luft FC.
    J Mol Med (Berl); 1997 Apr 05; 75(4):233-5. PubMed ID: 9151206
    [No Abstract] [Full Text] [Related]

  • 33. Burn control, an adipocyte-specific function for galectin-12.
    Baum LG.
    Proc Natl Acad Sci U S A; 2011 Nov 15; 108(46):18575-6. PubMed ID: 22058227
    [No Abstract] [Full Text] [Related]

  • 34. The effect of cilostazol on glucose tolerance and insulin resistance in a rat model of non-insulin dependent diabetes mellitus.
    Chang SA, Cha BY, Yoo SJ, Ahn YB, Song KH, Han JH, Lee JM, Son HS, Yoon KH, Kang MI, Lee KW, Son HY, Kang SK.
    Korean J Intern Med; 2001 Jun 15; 16(2):87-92. PubMed ID: 11590907
    [Abstract] [Full Text] [Related]

  • 35. Cellular cyclic AMP levels modulate insulin sensitivity and responsiveness--evidence against a significant role of Gi in insulin signal transduction.
    Wesslau C, Eriksson JW, Smith U.
    Biochem Biophys Res Commun; 1993 Oct 15; 196(1):287-93. PubMed ID: 8216302
    [Abstract] [Full Text] [Related]

  • 36. The cGMP-inhibitable phosphodiesterase modulates glucose transport activation by insulin.
    Eriksson JW, Wesslau C, Smith U.
    Biochim Biophys Acta; 1994 Jan 19; 1189(2):163-7. PubMed ID: 8292620
    [Abstract] [Full Text] [Related]

  • 37. The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP.
    Wesslau C, Smith U.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):41-6. PubMed ID: 1280115
    [Abstract] [Full Text] [Related]

  • 38. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW.
    Diabetologia; 1997 Oct 15; 40(10):1197-203. PubMed ID: 9349602
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets.
    Müller G, Wied S, Over S, Frick W.
    Biochemistry; 2008 Feb 05; 47(5):1259-73. PubMed ID: 18186616
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.